Back to News
Market Impact: 0.3
Sagimet Prices $115 Mln Stock Offering, Pre-market Shares Up
Source: Nasdaq
Company FundamentalsCapital Returns (Dividends / Buybacks)
Sagimet Biosciences priced an underwritten offering of 8.75 million Series A common shares at $10 per share, raising approximately $115 million. The capital raise strengthens the company's funding position but may dilute existing shareholders.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
SGMT0.35
More News
- RAM supply set to worsen, says Micron, as CEO celebrates ‘much higher’ prices
- Tencent leases 100,000 chips from Oracle for $7 bln- FT
- Why is Nidec stock plunging today?
- Nidec Corp shares slump after auditor declines to sign off on earnings
- We're raising our Micron price target after an incredible quarter and robust guidance
- Why is Kioxia stock rallying today?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AlphaSense vs Hebbia vs AllMind: Choose by Workflow
- AllMind Discusses Ontario's AI Economy with Minister Stephen Crawford and Supply Ontario CEO James Wallace